We are monitoring the impact of COVID-19 on North America Blood Screening Market Get in touch with us for detailed analysis Know More
Share on

North America Blood Screening Market Research Report - By Technology, Product, End User and Country (the United States, Canada & Rest of North America) - Industry Analysis, Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3176
Pages: 144

North America Blood Screening Market Size (2022 to 2027)

As per our report, the size of the North America Blood Screening Market was estimated to be USD 0.85 billion in 2022 and is expected to reach USD 1.37 billion by the year 2027, growing at a CAGR of 10.1% during the forecast period.

A few of the significant factors promoting the blood screening market in the North American region are the vast pool of patients, improved healthcare infrastructure, increasing disposable income, growing demand for donated blood, and growing government support. On the other hand, increasing awareness of the importance of maintaining the safety of donated blood, the rising prevalence of infectious diseases, and the growing demand for donated blood are majorly contributing to the market growth. 

In Addition, new technological advancements in blood screening, major market key players, increased healthcare concern, and a rising number of initiators like initiatives taken by the government are expected to propel the market growth. 

However, alternative technologies, such as digital immunoassay and a scarcity of qualified workers, are projected to restrain the North American blood screening market growth during the forecast period. Also, the Complex regulatory frameworks for approval, a shortage of experienced labor, competing technologies such as digital immunoassay, and expensive initial capital investment and testing expenses further limit the blood screening market growth.

This research report on the North American blood screening market has been segmented and sub-segmented into the following categories:

By Technology:

  • Nucleic Acid Amplification
  • Elisa
  • Rapid Test
  • NGS
  • Western Blotting

By Product:

  • Instruments
  • Reagent & Kits
  • Software

By End User:

  • Blood banks
  • Hospital

By Country:

  • The United States
  • Canada
  • Rest of North America

Based on the region, the market is exhibiting obvious potential in the specified forecast period. As of 20229, North America leads the global blood screening market with a share of 41%. The North American blood screening market is anticipated to account for the largest share in the global market during the forecast period due to the technical developments in blood screening technologies and the region's rising incidence of infectious diseases.  

Currently, North America is the leader among all the regions in the blood screening market owing to the rising demand for donated blood, the increasing number of blood donors, the proliferation of infectious diseases across the region. In Addition, the increase in the prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players are fuelling the market growth. 

KEY MARKET PLAYERS:

A few of the promising companies operating in the North America blood screening market profiled in the report are Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Ortho Clinical Diagnostics, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, Grifols, Siemens AG and Beckman Coulter, Inc.

1.Introduction 

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods            

                1.4 General Study Assumptions  

2. Research Methodology          

                2.1 Introduction                 

                2.2 Research Phases        

  2.2.1 Secondary Research                           

  2.2.2 Primary Research                 

  2.2.3 Econometric Modelling                      

  2.2.4 Expert Validation                  

                2.3 Analysis Design           

                2.4 Study Timeline            

3. Overview      

                3.1 Executive Summary  

                3.2 Key Inferences           

                3.3 Epidemology                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)   

                4.1 Market Drivers            

                4.2 Market Restraints      

                4.3 Key Challenges           

                4.4 Current Opportunities in the Market                

5. Market Segmentation             

                5.1 Technology   

  5.1.1 Nucliec Acid Amplification Test                       

                  6.3.1 Transcription-Mediated Amplification (TMA)           

                  6.3.2 Real-Time Polymerase Chain Reaction (PCR             

  5.1.2 rCPR                           

  5.1.3 ELISA                         

                  5.1.3.1 ELISA Market, By Platform            

            5.1.3.1.1 Chemiluminescence Immunoassay (CLIA)

            5.1.3.1.2 Fluorescence Immunoassay (FIA)

           5.1.3.1.3 Colorimetric Immunoassay (CI)

                  5.1.3.2 ELISA Market, By Generation      

           5.1.3.2.1 First-Generation ELISA

           5.1.3.2.2 Second-Generation ELISA

           5.1.3.2.3 Third-Generation ELISA

           5.1.3.2.4 Fourth-Generation & Above

  5.1.4 CLIA                           

  5.1.5 Flourescence Assay                             

  5.1.6 Rapid Test 

  5.1.7 NGS                           

  5.1.8 Western Blotting                  

  5.1.9  Y-o-Y Growth Analysis, By Technology                       

  5.1.10  Market Attractiveness Analysis, By Technology                   

  5.1.11  Market Share Analysis, By Technology                    

                5.2 Product          

  5.2.1 Instrument                             

                  5.2.1.1 Rental Purchase

                  5.2.1.2 Outright Purchase            

  5.2.2 Reagent and Kits                  

                  5.2.2.1 NAT Reagents & Kits       

           5.2.2.1.1 Enzymes and Polymerases

           5.2.2.1.2 Standards and Controls

           5.2.2.1.3 Probes and Primers

           5.2.2.1.4 Buffers, Nucleotides and Solutions

           5.2.2.1.5 Labeling and Detection Reagents

                  5.2.2.2 ELISA Reagents & Kits     

           5.2.2.2.1 Immunosorbents

            5.2.2.2.2 Controls

           5.2.2.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)

           5.2.2.2.4 Substrates (Of Enzymes)

           5.2.2.2.5 Sample Diluents and Wash Solutions

  5.2.3 Software                  

  5.2.4 Y-o-Y Growth Analysis, By Product 

  5.2.5 Market Attractiveness Analysis, By Product                             

  5.2.6 Market Share Analysis, By Product 

                5.3 End User        

  5.3.1 Blood Bank

  5.3.2 Hospital                    

  5.3.3 Y-o-Y Growth Analysis, By End User                             

  5.3.4  Market Attractiveness Analysis, By End User                          

  5.3.5  Market Share Analysis, By End User                            

  5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis             

                6.1 Introduction                 

  6.1.1 Regional Trends                    

  6.1.2 Impact Analysis                     

  6.1.3 Y-o-Y Growth Analysis                        

                  6.1.3.1 By Geographical Area     

                  6.1.3.2 By Technology   

                  6.1.3.3 By Product           

                  6.1.3.4 By End User        

  6.1.4  Market Attractiveness Analysis                     

                  6.1.4.1 By Geographical Area     

                  6.1.4.2 By Technology   

                  6.1.4.3 By Product           

                  6.1.4.4 By End User        

  6.1.5  Market Share Analysis                      

                  6.1.5.1 By Geographical Area     

                  6.1.5.2 By Technology   

                  6.1.5.3 By Product           

                  6.1.5.4 By End User        

                6.2 United States              

                6.3 Canada           

7.Strategic Analysis       

                7.1 PESTLE analysis           

  7.1.1 Political                     

  7.1.2 Economic                 

  7.1.3 Social                         

  7.1.4 Technological                         

  7.1.5 Legal                          

  7.1.6 Environmental                       

                7.2 Porter’s Five analysis                

  7.2.1 Bargaining Power of Suppliers                        

  7.2.2 Bargaining Power of Consumers                    

  7.2.3 Threat of New Entrants                     

  7.2.4 Threat of Substitute Products and Services

  7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis        

                8.1 Grifols             

  8.1.1 Overview                 

  8.1.2 Product Analysis                   

  8.1.3 Financial analysis                  

  8.1.4 Recent Developments                       

  8.1.5 SWOT analysis                       

  8.1.6 Analyst View                          

                8.2 Thermo Fisher Scientific          

                8.3 Roche Diagnostics      

                8.4 BioMerieux  

                8.5 Bio-Rad Laboratories                

                8.6 Siemens Heathineers               

                8.7 Abbott Laboratories                 

                8.8 Ortho Clinical diagnostics        

                8.9 Becton            

                8.10 Dickinson and Company       

                8.11 Beckman Coulter     

9.Competitive Landscape           

                9.1 Market share analysis              

                9.2 Merger and Acquisition Analysis         

                9.3 Agreements, collaborations and Joint Ventures           

                9.4 New Product Launches           

10.Market Outlook and Investment Opportunities         

Appendix          

                a) List of Tables  

                b) List of Figures                

  1. North America Blood Screening Market, By Technology, From 2022 - 2027 (USD Million)
  2. North America Nucliec Acid Amplification Market, By Region, From 2022 - 2027 (USD Million)
  3. North America rCPR Market, By Region, From 2022 - 2027 (USD Million)
  4. North America ELISA Market, By Region, From 2022 - 2027 (USD Million)
  5. North America CLIA Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Floured science Assay Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Rapid Test Market, By Region, From 2022 - 2027 (USD Million)
  8. North America NGS Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Western Blotting Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Blood Screening Market, By Product, From 2022 - 2027 (USD Million)
  11. North America Instrument Market, By Region, From 2022 - 2027 (USD Million)
  12. North America Reagent and Kits Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Software Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Blood Screening Market, By End User, From 2022 - 2027 (USD Million)
  15. North America Blood Bank Market, By Region, From 2022 - 2027 (USD Million)
  16. North America Hospital Market, By Region, From 2022 - 2027 (USD Million)
  17. United States Blood Screening Market, By Technology, From 2022 - 2027 (USD Million)
  18. United States Blood Screening Market, By Product, From 2022 - 2027 (USD Million)
  19. United States Blood Screening Market, By End User, From 2022 - 2027 (USD Million)
  20. Canada Blood Screening Market, By Technology, From 2022 - 2027 (USD Million)
  21. Canada Blood Screening Market, By Product, From 2022 - 2027 (USD Million)
  22. Canada Blood Screening Market, By End User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample